Q4 2024 Merck KGaA Earnings Call Transcript

Author's Avatar
Mar 06, 2025

Mar 06, 2025 / 01:00PM GMT
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the fourth quarter 2024. (Operator Instructions) I am now handing over to Florian Schraeder, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Florian Schroeder - Mercedes-AMG GmbH - Head of IR

Thank you very much, Heidi, and warm welcome to everyone joining us for this Q4 and full year '24 earnings call. My name is Florian Schraeser, I'm Head of Investor Relations at Merck. I am delighted to be joined by Belen Garijo, Co-CEO, as well as Helene von Roeder, Group CFO. For the Q&A part of the call, we will also have with us here in the room, Matthias Heinzel, CEO of Life Science; Peter Guenter, CEO of Healthcare; and Kai Beckmann, CEO of Electronics.

As you surely have noticed, we recently announced upcoming changes to the Executive Board. I'm pleased to share that both Jean-Charles Wirth, appointed CEO, Life Science as of June 1; as well as Danny Bar-Zohar, appointed CEO, Healthcare as of June 1, will join us later today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot